Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07217158
Role of ROS and cAMP-PKA Biomarkers in ADPKD
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The primary objective is to determine the prognostic value of markers of ROS and cAMP-PKA signaling to assess disease severity and progression in patients with ADPKD.
Official title: Role of ROS and cAMP-PKA Signaling-related Biomarkers on Renal Disease Severity and Progression in ADPKD
Key Details
Gender
All
Age Range
15 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-07-01
Completion Date
2027-06-30
Last Updated
2025-10-27
Healthy Volunteers
No
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States